Samsung Galaxy Ring 2 Launches March 2026 With ECG
Samsung's second-generation smart ring adds FDA-cleared ECG and AFib detection. Direct Oura competitor at $299.
Samsung has officially announced the Galaxy Ring 2, launching March 15, 2026, with FDA-cleared electrocardiogram (ECG) measurement and passive atrial fibrillation (AFib) detection—making it the first smart ring to offer medical-grade cardiac monitoring. Priced at $299, the Galaxy Ring 2 undercuts Oura Ring Gen 3 ($349) by $50 while adding clinical cardiac features Oura completely lacks, positioning Samsung as a credible challenger in the smart ring market it entered just one generation ago.
The Galaxy Ring 2 represents Samsung's aggressive push into wearable health technology beyond smartwatches, targeting users who want comprehensive health tracking without the bulk of a wrist-worn device. By integrating ECG—a feature previously exclusive to smartwatches like Apple Watch and Samsung's own Galaxy Watch—into a 7mm-thick titanium ring, Samsung is betting it can steal market share from Oura's 1 million+ users while simultaneously converting Galaxy Watch owners who prefer a discreet form factor.
The ECG Feature: How It Works in a Ring
Two-Finger Touch Methodology
The Galaxy Ring 2's ECG sensor uses a two-electrode design similar to Apple Watch's implementation, but adapted for the ring form factor:
- Primary electrode: Embedded in the ring's inner surface (contacts finger wearing the ring)
- Secondary electrode: Exposed on the ring's outer surface (user touches with opposite hand's finger)
- Circuit completion: Electrical signal travels through torso between hands, capturing heart's electrical activity
- Measurement duration: 30 seconds (standard for single-lead ECG)
FDA Clearance Details
Samsung received FDA 510(k) clearance (Class II medical device) for the Galaxy Ring 2 ECG feature in December 2025, following a validation study comparing ring ECG readings to standard 12-lead hospital ECG:
- Sample size: 847 participants (ages 22-78)
- AFib detection sensitivity: 94.7% (correctly identifies AFib when present)
- Specificity: 97.2% (correctly identifies normal sinus rhythm when AFib absent)
- Comparison: Competitive with Apple Watch Series 9 ECG (95-98% sensitivity, 99% specificity)
Clinical Significance: The Galaxy Ring 2 meets FDA accuracy standards for AFib screening devices, making it suitable for cardiovascular risk awareness (not diagnosis—physician evaluation still required for medical decisions).
Passive AFib Detection (Background Monitoring)
Beyond on-demand ECG, the Galaxy Ring 2 includes passive AFib monitoring using photoplethysmography (PPG) heart rate sensor:
- Continuous HR monitoring: PPG sensor tracks heart rate 24/7
- Irregular rhythm detection: Algorithm identifies irregular beat patterns consistent with AFib
- Notification system: If irregular rhythm detected, prompts user to confirm via 30-second ECG
- False positive management: Requires 3+ irregular rhythm episodes over 48 hours before alerting (reduces spurious notifications)
Why This Matters: Most AFib is asymptomatic—people don't feel symptoms until complications (stroke, heart failure) occur. Passive monitoring catches AFib episodes that users wouldn't know to measure via on-demand ECG.
Beyond ECG: Complete Feature Set
Sleep Tracking (PSG-Validated)
Samsung validated the Galaxy Ring 2's sleep staging algorithm against polysomnography (PSG, the clinical gold standard):
- Validation study: 120 participants, overnight sleep lab testing
- Sleep stage concordance: 84% agreement with PSG for deep sleep detection, 81% for REM sleep
- Comparison: Competitive with Oura Ring Gen 3 (88% deep sleep concordance) but slightly less accurate
Sleep Metrics Provided:
- Total sleep time
- Sleep stages (light, deep, REM)
- Sleep latency (time to fall asleep)
- Awakenings during night
- Sleep Score (0-100 composite metric)
Activity & Fitness Tracking
- Step counting: Accelerometer-based (standard accuracy ±5-8% vs manual count)
- Auto activity detection: Walking, running, cycling recognized automatically
- Active calories: Estimated from HR + movement (less accurate than chest strap but adequate for trends)
- Workout HR tracking: Continuous heart rate during exercise
What's Missing vs Smartwatches: No GPS (cannot track outdoor run routes/pace), no altimeter (no stair climbing/elevation), no workout-specific metrics (VO2 max, training load).
Battery Life: 7 Days
Samsung claims 7-day battery life with typical use (24/7 wear, sleep tracking, 2-3 ECG measurements per week). This matches Oura Ring Gen 3's maximum battery life (4-7 days depending on usage).
Charging: Wireless charging case (similar to AirPods), 0-100% charge in 80 minutes.
Hardware Specifications
Build Quality & Materials
| Specification | Galaxy Ring 2 | Oura Ring Gen 3 |
|---|---|---|
| Material | Titanium (Grade 5) | Titanium (Grade 5) |
| Thickness | 7.0mm | 7.9mm |
| Weight | 3.2-3.8g (size dependent) | 4.0-6.0g (size dependent) |
| Water Resistance | 10 ATM (100m) | 10 ATM (100m) |
| Available Sizes | 9 sizes (5-13 US ring sizes) | 8 sizes (6-13 US ring sizes) |
| Color Options | Black, Silver, Gold | Silver, Black, Stealth, Gold, Rose Gold, Brushed Silver |
Build Quality Verdict: Both rings use identical titanium grade and water resistance. Galaxy Ring 2 is marginally thinner/lighter, but differences are negligible in real-world comfort.
The Samsung Ecosystem Lock-In
Android-Only Compatibility
The Galaxy Ring 2's most significant limitation: requires Samsung Galaxy smartphone or tablet. No iOS support, no compatibility with non-Samsung Android devices.
Compatibility Requirements:
- Samsung Galaxy S23 or newer (requires One UI 6.0+)
- Samsung Galaxy Z Fold 5 / Flip 5 or newer
- Samsung Galaxy Tab S9 or newer
- Samsung Health app (pre-installed on Samsung devices)
- Samsung account (required for data sync)
Why No iOS Support?
Samsung claims technical limitations (FDA-cleared ECG feature requires tight integration with Samsung Health platform), but the reality is strategic: Samsung wants Galaxy Ring 2 to drive smartphone sales, not cannibalize them by supporting competitors.
Market Impact:
- US smartphone market: 60% iOS, 40% Android
- Samsung's Android share: ~30% of total US market (18% of all smartphone users)
- Addressable market: Galaxy Ring 2 can only target 18% of US smartphone users vs Oura's device-agnostic approach
Samsung Health Integration
For Samsung Galaxy users, the integration is seamless:
- Unified health dashboard: Ring data merges with Galaxy Watch data (if user owns both)
- Third-party sync: Data exports to Google Fit, Health Connect (Android's health data platform)
- No subscription required: All features included with hardware purchase (vs Oura's $5.99/month membership)
Pricing & Competitive Analysis
Price Comparison
| Device | Hardware Price | Subscription | 3-Year Total Cost |
|---|---|---|---|
| Samsung Galaxy Ring 2 | $299 | $0 | $299 |
| Oura Ring Gen 3 | $349 | $5.99/month | $564.64 |
| Apple Watch Series 9 | $399 | $0 | $399 |
Samsung's Value Proposition: $299 upfront, no ongoing costs. Oura costs $265 more over 3 years due to subscription. Galaxy Ring 2 is cheaper long-term despite adding ECG feature Oura lacks.
Feature Comparison: Galaxy Ring 2 vs Oura Gen 3
| Feature | Galaxy Ring 2 | Oura Ring Gen 3 |
|---|---|---|
| ECG / AFib Detection | Yes (FDA-cleared) | No |
| Sleep Tracking Accuracy | Good (84% PSG concordance) | Excellent (88% PSG concordance) |
| HRV Tracking | Yes (RMSSD) | Yes (RMSSD, superior accuracy) |
| Battery Life | 7 days | 4-7 days |
| Device Compatibility | Samsung Galaxy only | iOS & Android |
| Price (3-year TCO) | $299 | $565 |
Trade-off Summary: Galaxy Ring 2 wins on ECG, price, battery life. Oura wins on sleep accuracy, HRV precision, device compatibility.
Market Strategy: Can Samsung Steal Oura's Users?
Samsung's Competitive Advantages
- ECG differentiation: Only smart ring with FDA-cleared cardiac monitoring
- Lower total cost: $265 savings over 3 years vs Oura (no subscription)
- Ecosystem integration: Seamless pairing with Galaxy Watch for users who own both
- Retail presence: Samsung stores, Best Buy, carrier stores (wider distribution than Oura's direct-to-consumer model)
Oura's Defensive Moat
- Superior sleep accuracy: 88% vs 84% PSG concordance matters for sleep optimization enthusiasts
- Platform independence: Works with iPhone (60% of US premium market), all Android devices
- Brand loyalty: Oura has 1M+ users with 12-18 months average retention—switching costs are high
- Data insights: Oura's Readiness, Sleep, and Activity scores are refined from 5+ years user data
Who Switches from Oura to Samsung?
- Samsung Galaxy users with cardiovascular concerns: ECG feature is compelling for AFib risk (family history, over 50 age)
- Cost-conscious users: Saving $265 over 3 years matters for budget-limited buyers
- Dual device users: People who own Galaxy Watch + want ring for sleep tracking without subscription stacking
Who Stays with Oura?
- iPhone users: 60% of US premium market cannot use Galaxy Ring 2
- Sleep optimization purists: Oura's 88% sleep staging accuracy > Samsung's 84%
- Non-Samsung Android users: Pixel, OnePlus, Motorola owners locked out of Galaxy Ring 2
Launch Timeline & Availability
Pre-Orders & Shipping
- Pre-order start: February 1, 2026
- General availability: March 15, 2026
- Sizing kit: Free sizing kit ships within 3-5 business days (must return after determining correct size)
- Final ring shipment: 7-10 business days after sizing kit return
Where to Buy
- Samsung.com
- Samsung Experience Stores
- Best Buy (online and in-store)
- Carrier stores (Verizon, AT&T, T-Mobile)
The Bottom Line: Compelling for Galaxy Users, Irrelevant for iPhone Users
The Samsung Galaxy Ring 2 is an impressive piece of hardware—FDA-cleared ECG in a 7mm titanium ring is a genuine engineering achievement. The $299 price point with no subscription undercuts Oura by $265 over 3 years while adding cardiac monitoring Oura completely lacks. For Samsung Galaxy smartphone users concerned about cardiovascular health, this is a no-brainer purchase.
But the Android-only restriction is a self-inflicted wound. By locking out iPhone users (60% of US premium market) and non-Samsung Android users (another 20%), Samsung limits its addressable market to ~18% of US smartphone users. Oura, by contrast, works with every smartphone—iOS, Android, any brand.
Who should buy Galaxy Ring 2:
- Samsung Galaxy users wanting ECG + sleep tracking without smartwatch bulk
- People over 50 with AFib risk factors (family history, hypertension)
- Cost-conscious buyers ($299 vs $565 total for Oura over 3 years)
Who should stick with Oura:
- iPhone users (Galaxy Ring 2 incompatible)
- Sleep optimization purists (Oura's 88% accuracy > Samsung's 84%)
- Non-Samsung Android users (Pixel, OnePlus, etc.)
Samsung has built a credible Oura competitor—but only for the 18% of users who own Samsung Galaxy devices. That's a niche within a niche. Impressive product, questionable strategy.
Available March 15, 2026. Pre-orders open February 1.